Ori Zelichov is a physician-entrepreneur and the Co-Founder, Chief Medical Officer, and President of ZipBio. Prior to founding ZipBio, Ori spent over a decade as Chief Medical Officer at multiple biotech companies, including Fore Biotherapeutics and Nucleai. He is the inventor of multiple patents and has spearheaded the development of numerous groundbreaking therapeutic and diagnostic products, including plixorafenib, a novel drug for brain cancer currently undergoing pivotal human trials. Ori holds an MD from Ben-Gurion University and is a graduate of the Medical Innovation Program at MIT and Harvard Medical School.